Renal & Urology

End-Stage Renal Disease

Kidney failure is stage 5 chronic kidney disease with insufficient renal function to maintain homeostasis; care is planned around symptoms, biochemical complications, patient goals and the choice between dialysis, transplantation and supported conservative management.

In a nutshell

Kidney failure is CKD G5 (eGFR below 15), but dialysis is not started from eGFR alone. Plan early for transplant, haemodialysis, peritoneal dialysis or active conservative management. Dialyse for uraemic symptoms, uncontrolled fluid overload or biochemical complications; consider around eGFR 5 to 7 without symptoms. Urgently refer refractory hyperkalaemia, acidosis, uraemic pericarditis/encephalopathy, fluid overload or pulmonary oedema.

Classic presentation

A person with progressive CKD develops anorexia, nausea, pruritus, fatigue, oedema, breathlessness, anaemia, hyperkalaemia and acidosis, and needs a shared decision about renal replacement or conservative care.

Key points

  • G5 is eGFR below 15 mL/min/1.73 m2; eGFR alone does not determine dialysis.
  • Plan RRT or conservative management at least 1 year before it is likely to be needed.
  • Transplantation offers the best survival and quality-of-life outcomes for suitable people; consider pre-emptive transplant.
  • If haemodialysis is chosen, aim to create an AV fistula around 6 months before anticipated dialysis when suitable.
  • Start dialysis for uraemic symptoms, biochemical measures or uncontrollable fluid overload; consider eGFR 5 to 7 without symptoms.
  • Refractory hyperkalaemia, acidosis, uraemic pericarditis/encephalopathy, fluid overload or pulmonary oedema require immediate renal/critical-care referral.
  • Conservative management is active, supported, person-centred care.

First-line investigation

Serial eGFR and U&E with potassium/bicarbonate, symptom and fluid assessment, FBC/iron, calcium/phosphate/PTH, urinalysis/ACR and cause/chronicity assessment.

Management

Recognise urgent complications

  • Refractory hyperkalaemia, acidosis, uraemic pericarditis/encephalopathy, fluid overload or pulmonary oedema require immediate nephrology/critical-care referral for RRT.3

Plan before crisis

  • Start shared assessment for transplant, haemodialysis, peritoneal dialysis or conservative care at least 1 year before likely RRT.2
  • Assess eGFR trend, symptoms, fluid, potassium, bicarbonate, anaemia and mineral-bone disorder; do not use one result in isolation.2,1

Start the chosen RRT

  • Dialysis is driven by symptomatic uraemia, biochemical measures or uncontrollable fluid overload; around eGFR 5 to 7 without symptoms is a consideration, not an automatic trigger.2

Protect long-term goals

  • Monitor access, dialysis adequacy, anaemia, phosphate/calcium/PTH, nutrition, cardiovascular risk and psychological wellbeing, with ongoing review of transplant or conservative-care goals.2,1

Exam traps

  • Do not start dialysis from eGFR alone.
  • Do not delay emergency referral for refractory hyperkalaemia, acidosis, pulmonary oedema or uraemic complications while waiting for a planned dialysis date.
  • Do not describe conservative management as non-treatment.
  • Do not start ESA without addressing absolute iron deficiency.
  • Do not assume one dialysis modality or a fixed weekly schedule suits every patient.
  • Do not forget superimposed AKI, obstruction, nephrotoxicity or sepsis.

Illustrations

Arteriovenous fistula during haemodialysisA forearm arteriovenous fistula connected to a haemodialysis circuit, with the image labelled as planned vascular access rather than a substitute for access assessment.Anna Frodesiak, Wikimedia Commons · CC0

Key sources

  1. NICE NG203, Chronic kidney disease: assessment and management (NICE guideline published 25 August 2021 with current recommendations on G5 CKD, anaemia, phosphate binders and monitoring)Published 25 Aug 2021
  2. NICE NG107, Renal replacement therapy and conservative management (NICE guideline published 3 October 2018; 2023 surveillance found no new evidence affecting recommendations)Published 3 Oct 2018
  3. NICE NG148, Acute kidney injury: prevention, detection and management (NICE RRT referral criteria updated in 2023; includes refractory hyperkalaemia, acidosis, uraemic complications, fluid overload and pulmonary oedema)Published 18 Dec 2019
  4. BNF, current renal impairment and renal replacement therapy prescribing information (Use current monographs for renal dosing, ESA, iron, phosphate binder, vitamin D and cardiovascular medicines)

This page is exam revision material, not medical advice, and must not be used for patient care. Always check drug doses against the BNF and current guidance. Full disclaimer.